These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
521 related items for PubMed ID: 10099139
1. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. International Perinatal HIV Group, Andiman W, Bryson Y, de Martino M, Fowler M, Harris D, Hutto C, Korber B, Kovacs A, Landesman S, Lindsay M, Lapointe N, Mandelbrot L, Newell M-L, Peavy H, Read J, Rudin C, Semprini A, Simonds R, Tuomala R. N Engl J Med; 1999 Apr 01; 340(13):977-87. PubMed ID: 10099139 [Abstract] [Full Text] [Related]
2. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Bénifla JL, Delfraissy JF, Blanche S, Mayaux MJ. JAMA; 1998 Jul 01; 280(1):55-60. PubMed ID: 9660364 [Abstract] [Full Text] [Related]
9. [Changes in vertical HIV transmission: comparison between 1994 and 2004]. Orío M, Peña JM, Rives MT, Sanz M, Bates I, Madero R, de José MI. Med Clin (Barc); 2007 Mar 10; 128(9):321-4. PubMed ID: 17376357 [Abstract] [Full Text] [Related]
10. A "bloodless cesarean section" and perinatal transmission of the human immunodeficiency virus. Towers CV, Deveikis A, Asrat T, Major C, Nageotte MP. Am J Obstet Gynecol; 1998 Sep 10; 179(3 Pt 1):708-14. PubMed ID: 9757976 [Abstract] [Full Text] [Related]
11. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1. Panburana P, Sirinavin S, Phuapradit W, Vibhagool A, Chantratita W. Am J Obstet Gynecol; 2004 Mar 10; 190(3):803-8. PubMed ID: 15042018 [Abstract] [Full Text] [Related]
12. Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations. Read JS. Ann N Y Acad Sci; 2000 Nov 10; 918():115-21. PubMed ID: 11131694 [Abstract] [Full Text] [Related]
14. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1? Galli L, Puliti D, Chiappini E, Gabiano C, Ferraris G, Mignone F, Viganò A, Giaquinto C, Genovese O, Anzidei G, Badolato R, Buffolano W, Maccabruni A, Salvini F, Cellini M, Ruggeri M, Manzionna M, Bernardi S, Tovo P, de Martino M, Italian Register for HIV Infection in Children. Clin Infect Dis; 2009 May 01; 48(9):1310-7. PubMed ID: 19309307 [Abstract] [Full Text] [Related]
15. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010. Briand N, Jasseron C, Sibiude J, Azria E, Pollet J, Hammou Y, Warszawski J, Mandelbrot L. Am J Obstet Gynecol; 2013 Oct 01; 209(4):335.e1-335.e12. PubMed ID: 23791563 [Abstract] [Full Text] [Related]
18. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. N Engl J Med; 1996 Nov 28; 335(22):1621-9. PubMed ID: 8965861 [Abstract] [Full Text] [Related]
20. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women. Kowalska A, Niemiec T, El Midaoui A, Burkacka E. Med Wieku Rozwoj; 2003 Nov 28; 7(4 Pt 1):459-68. PubMed ID: 15010556 [Abstract] [Full Text] [Related] Page: [Next] [New Search]